Kiniksa Pharmaceuticals International, plc

KNSA·NasdaqGS·Healthcare
Compare
96.12+2.83 (+3.03%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD
Pre-market96.00−0.12 (−0.12%)

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close93.29
Open93.63
Day range91.7496.28
52-week range37.0298.48
Off day high−0.16%
Off 52-week high−2.40%
Volume860.51K
Avg. volume (3M)639.13K
Market cap7.55B
EPS (TTM)1.32
Forward P/E44.04
P/E ratio (TTM)72.82
Dividend yield—
Beta (5Y)0.08
Shares outstanding48.84M
Short interest9.31% of float
Earnings dateOct 27, 2026
Analyst target109.43
Profit margin11.58%

Against its peers

Compare in full ›
KNSA KY4.F BCRX KILITCH.NS KRK.WA MRK.F
Market cap 7.55B 7.59B 2.11B 7.29B 33.00B 65.87B
P/E (TTM) 72.8 16.9 — 23.7 18.6 27.8
Forward P/E 44.0 17.7 10.0 13.6 — 16.7
Price/book 10.6 1.5 -14.7 2.6 12.6 2.2
Dividend yield — 2.89% — — 3.61% 1.49%
1-year change +148.82% +1.49% +17.21% +3.92% +22.70% +37.23%
Today +3.03% +6.62% −3.85% −0.21% −0.18% +0.50%

The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.

Latest news

All KNSA news ›
Defense World··2 outletsPositive

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) vs. Cytokinetics (NASDAQ:CYTK) Head-To-Head Review

Posted by Defense World Staff on Oct 25th, 2026 Kiniksa Pharmaceuticals International (NASDAQ:KNSA – Get Free Report) and Cytokinetics (NASDAQ:CYTK – Get Free Report) are both mid-cap healthcare companies, but which is the superior…

More from 1 other outlet

From the 4Search news index, newest first.

In the news

16mentions in 30 days
11with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 16 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance